A great all-in-one platform to quickly understand new therapeutic areas
July 30, 2022

A great all-in-one platform to quickly understand new therapeutic areas

Anonymous | TrustRadius Reviewer
Score 9 out of 10
Vetted Review
Verified User

Overall Satisfaction with AlphaSense

I regularly deal with complex forecasts in new disease areas, with fast turnaround times needed. AlphaSense helps me access the key information in one place, by providing company documents, analyst reports, and medical articles at a click of a button. The analyst reports are particularly useful and help me get a deep dive into any new disease area at a moment's notice.
  • Gather a lot of relevant content in one place
  • Keep users updated of new features and data source
  • Provide a simple, clear interface that can be customised to address each user's needs
  • The search functionality could be improved, the results are not always the most relevant
  • A clear view of the user's balance would be useful too
  • More analysts' reports (from new sources) would be helpful
  • KOL input (similar to what Guidepoint provides)
  • Clearer business cases
  • More responsive CI team
  • Added confidence in BD business cases
AlphaSense's platform is more usable than most similar platforms and I usually find what I am looking for (if it exists) fairly quickly. However, the search functionality is not always the clearest in its results, and there should be a functionality to restrict a search field to a specific industry, so as not to get results using the right keywords but in completely unrelated fields or industries.
AlphaSense has been incredibly helpful in helping us shape the stories behind our business cases, and getting a clearer, crisper understanding of the competition and what's top of mind for the analysts. The service has also been invaluable in enabling us to get up to speed quickly on new disease areas, especially during BD cases.
The user interface is simpler, and AlphaSense also provides a much broader range of data, with often a lot of thinking on the "why" of a certain forecast or why a certain therapeutic area is promising. Another competitor we look at a lot is Evaluate Pharma, which is very strong on financials, but lacks depth.

Do you think AlphaSense delivers good value for the price?


Are you happy with AlphaSense's feature set?


Did AlphaSense live up to sales and marketing promises?


Did implementation of AlphaSense go as expected?


Would you buy AlphaSense again?


Well suited: Business development cases, where a fast turnaround of a robust forecast is crucial - Deep dives into new therapeutic areas, where limited CI data is available - Continuous CI monitoring, especially following big data releases

Not well suited: In-depth information around pricing or epidemiology - Not the absolute source of truth for forecasts